Dearborn Dan 4
4 · TuHURA Biosciences, Inc./NV · Filed Jan 8, 2026
Insider Transaction Report
Form 4
Dearborn Dan
Chief Financial Officer
Transactions
- Award
Options (Right to Buy)
2026-01-06+273,696→ 273,696 totalExercise: $0.73Exp: 2036-01-06→ Common Stock (273,696 underlying)
Footnotes (1)
- [F1]Represents a supplemental option grant to the option grant previously made in December 2025. One-third of the stock options become exercisable on the first, second, and third anniversary of January 6, 2025.